Skip to main content
Harrow Health, Inc. (HROW)
NASDAQ: HROW · IEX Real-Time Price · USD
24.44
+0.21 (0.87%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Harrow Health Revenue

Harrow Health had revenue of $34.59M in the quarter ending March 31, 2024, with 32.50% growth. This brings the company's revenue in the last twelve months to $138.68M, up 49.79% year-over-year. In the year 2023, Harrow Health had annual revenue of $130.19M with 46.95% growth.

Revenue (ttm)
$138.68M
Revenue Growth
+49.79%
P/S Ratio
6.21
Revenue / Employee
$440,244
Employees
315
Market Cap
864.73M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023130.19M41.60M46.95%
Dec 31, 202288.60M16.12M22.24%
Dec 31, 202172.48M23.61M48.30%
Dec 31, 202048.87M-2.29M-4.48%
Dec 31, 201951.17M9.79M23.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Pennant Group 575.34M
GeneDx Holdings 221.85M
Cytek Biosciences 200.79M
Standard BioTools 126.76M
Liquidia 15.97M
Mesoblast 7.25M
Dianthus Therapeutics 2.26M
Perspective Therapeutics -304.00K
Revenue Rankings

HROW News

More News